Advertisements

Dolobene (Heparin)

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Dolobene (Heparin)

Quick Facts

Property Description
Active Ingredients Heparin Sodium, Dimethyl Sulfoxide (DMSO), Dexpanthenol
Form Topical Gel
Pharmacological Class Combination Topical Anticoagulant and Anti-inflammatory Agent
Route of Administration Dermal (Topical)
Origin Heparin: Natural derivative (mucopolysaccharide); Others: Synthetic/Derivative

What Type of Medicine is Dolobene (Heparin)?

Dolobene is a specific pharmaceutical preparation classified as a combination topical anticoagulant and anti-inflammatory agent, presented as a Topical Gel for external, dermal application. This medicine is characterized by its triple-active composition, which aims to provide localized supportive care. As a topical gel, its mechanism of action is primarily concentrated at the application site, offering non-systemic relief for symptoms associated with localized trauma and reducing tissue discomfort.

Understanding the Triple-Active Composition

The defining feature of Dolobene is its inclusion of three Active Ingredients [INN]: Heparin Sodium, Dimethyl Sulfoxide (DMSO), and Dexpanthenol. Heparin Sodium is an anionic sulfated glycosaminoglycan polymer derived from natural sources, included for its localized anti-edema (anti-swelling) properties. The addition of DMSO is a key differentiator; this ingredient serves as a powerful penetration enhancer, which allows the active ingredients to pass effectively through the skin barrier to reach deeper tissues. Finally, Dexpanthenol, a derivative of Pro-vitamin B5, is specifically included to assist in the natural healing and tissue regeneration process.

What is the General Benefit of Dolobene Gel?

The general benefit of Dolobene gel is its comprehensive, multi-action approach to soft tissue injuries, providing simultaneous support against swelling and contributing to localized pain relief. The unique combination is designed to quickly counteract the common symptoms associated with localized trauma, such as swelling, bruising, and discomfort following minor blunt injuries like strains and sprains. This formulation offers a targeted, easy-to-use option for supporting tissue recovery directly at the site of ailment.

Advertisements

What side effects are possible with Dolobene (Heparin)?

Possible Side Effects and Safety Information

The official regulatory safety profile for this topical gel is structured by classification of adverse reactions and specific usage limitations. The majority of documented side effects are concentrated at the site of application (dermatological reactions), reflecting the topical route of administration.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped according to their incidence as defined in regulatory documents:

  • Common: Local skin reactions, including redness (erythema), itching (pruritus), a burning sensation, and the development of hives (urticaria).
  • Uncommon: Hypersensitivity manifestations such as contact dermatitis or localized blistering (bullous eruptions).
  • Not Known: Systemic allergic responses (e.g., severe anaphylaxis) and a transient garlic-like odor on the breath or body, a known consequence of systemic absorption of Dimethyl Sulfoxide (DMSO) metabolites.

These effects are classified within the Skin and subcutaneous tissue disorders and Immune system disorders System-Organ Classes.

Safety Restrictions and Special Considerations

Official labeling includes specific restrictions derived from the potential for systemic absorption, even with topical use. The gel is contraindicated in individuals with a known hypersensitivity to any of the active ingredients (Heparin sodium, DMSO, Dexpanthenol).

Furthermore, the product must not be used by patients with severe hepatic or renal dysfunction or bronchial asthma. Caution is specifically advised because the systemic clearance of DMSO metabolites can be compromised in patients with severe liver or kidney impairment. Local application is strictly prohibited on open wounds, damaged skin, mucous membranes, or near the eyes. Some local reactions, such as the burning sensation, are officially noted as being transient and more common at the start of treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The primary risk associated with overdose from this topical gel stems from the systemic effects of the Heparin Sodium component, which may occur following accidental ingestion or excessive application on large, compromised skin areas. Regulatory documents classify this risk as potentially severe, with life-threatening condition and fatal outcomes documented as possible consequences of uncontrolled systemic hemorrhage.

Documented Overdose Manifestations

Manifestation Type Description (as per Regulatory Labeling)
Hemorrhagic Signs Uncontrolled bleeding, bruising, petechiae, and blood in bodily fluids.
Physiological Signs Unexplained fall in hematocrit, fall in blood pressure, and cardiovascular collapse.
Local Signs Increased haematomas due to high concentration exposure.

Emergency Actions Required

Regulatory authorities mandate that individuals seek immediate medical attention upon suspicion of accidental ingestion or the observation of any signs of bleeding. For accidental ingestion, supportive measures listed for consideration include Gastric lavage and the administration of Activated charcoal. If hemorrhage occurs, the product must be promptly discontinued.

Management in a monitored setting requires frequent blood coagulation tests and monitoring of hematocrit and platelet levels. The documented agent for neutralizing the anticoagulant effects of Heparin is Protamine sulphate.

Advertisements

Therapeutic Uses of Dolobene (Heparin)

What Dolobene (Heparin) Treats: Main Uses and Benefits

The therapeutic application of Dolobene Gel is concentrated on providing localized support to manage key symptom clusters associated with soft tissue trauma and inflammation. It is applied across domains where additional symptomatic support is needed and contributes to improved comfort during periods of heightened symptoms. The gel is commonly used in conditions presenting with localized discomfort following injury.

Symptom Relief in Common Trauma

Dolobene is relevant for easing symptoms related to swelling (edema), vascular discoloration (hematoma or bruising), and localized pain. It is used in clinical settings that involve acute episodes following blunt trauma, such as sprains, strains, and contusions. The supportive relief helps address symptom clusters that create noticeable physiological strain and supports patients during episodes of heightened discomfort.

The medication is relevant for easing symptoms associated with the discomfort and tenderness from localized tendonitis and bursitis, and the feelings of heaviness experienced in situations where patients have superficial venous inflammation.

“It provides support that helps ease the overall symptom burden associated with common physical strain and trauma.”

Quick Fact: Relief for Localized Discomfort
Primary Focus: Symptomatic management of pain, swelling, and bruising after soft tissue injuries.
Usage Context: Acute episodes of trauma, muscle/tendon inflammation, and localized venous discomfort.
Benefit: Supports the process of resorption of bruising and contributes to easing the overall symptom load.

Regulatory References

  1. Official Swissmedic Patient Information for Dolobene Gel
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The eligibility profile for Dolobene ratiopharm Gel (Heparin, DMSO, Dexpanthenol) is strictly defined by regulatory documents, which establish several absolute prohibitions on its use.

Classification Excluded Groups/Conditions
Absolute Contraindications Hypersensitivity to any component; Asthma; Severe renal or hepatic function restriction; Circulatory instability; Pregnancy; Breastfeeding.
Age Restriction Children under 5 years (Use is prohibited due to lack of experience/data).
Conditional Use Must not be applied to mucous membranes (eyes, mouth, nose), open wounds, or diseased/previously damaged skin.

Eligibility-Related Restrictions

The gel must be used only by patients who do not fall into the contraindicated groups. Specifically, the regulatory labeling emphasizes strict non-eligibility for pregnant and breastfeeding women, stating the product must not be used during these life stages. Furthermore, due to the component Dimethyl Sulfoxide (DMSO), its use is strictly prohibited in patients with severely impaired liver or kidney function. These rules reflect the formal regulatory classification of who is permitted and who is strictly forbidden from using the medicine.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding drug interactions for the topical Dolobene Gel is structured around the pharmacological attributes of its three active components, specifically the risk profile of Heparin Sodium and the function of Dimethyl Sulfoxide (DMSO) as a penetration enhancer.

Pharmacodynamic and Exposure-Modifying Interactions

Co-administration with other medications that affect blood clotting, such as systemic anticoagulants or antiplatelet agents, may lead to a pharmacodynamic reinforcement. This additive effect increases the potential for localized adverse outcomes like bruising or bleeding at the application site.

The inclusion of DMSO carries specific interaction constraints by altering dermal delivery. Regulatory documentation indicates that the co-application of other topical medications may result in an increased systemic or local exposure (AUC/Cmax) to those co-administered substances due to the penetration-enhancing effect.

Specific Drug Interactions

Specific interactions involving the DMSO component have been noted in regulatory contexts. Co-administration has been reported to reduce the effectiveness of the drug Sulindac and may carry an increased risk of neurotoxic effects. Similarly, co-administration with the drug Verteporfin has also been reported to result in reduced effectiveness of that medication. No mandatory timing-based separation rules or specific interactions with food, alcohol, or herbal products are explicitly documented in regulatory labels for the topical gel.

Advertisements

Mechanism of Action

Dual Mechanism for Modulating Leukocyte Recruitment and Edema Cascade

The gel's action involves simultaneously modulating inflammation and the resultant fluid accumulation through two molecular pathways. Heparin Sodium acts by blocking P-selectin and L-selectin, which are adhesion molecules that regulate the ability of immune cells to migrate into injured tissue, thereby influencing an early step of the leukocyte recruitment cascade. This action is complemented by Dimethyl Sulfoxide (DMSO), which suppresses the phosphorylation of signaling proteins (e.g., in the MAPK pathway), leading to a reduction in the expression of pro-inflammatory cytokines within the cells.


Penetration Facilitation and Modulation of Local Peripheral Nociceptive Signaling

DMSO provides the essential mechanism of enhanced dermal delivery, acting as a powerful penetration facilitator that rapidly increases the permeability of the skin's outer layers. This facilitates the necessary concentration gradient for Heparin and Dexpanthenol to develop in the underlying soft tissues. Separately, DMSO also exhibits a direct physiological effect by modulating local nerve impulse transmission, essentially creating a localized nerve blockade that suppresses local transmission of peripheral nociceptive signals.


Activation of Cellular Metabolic Support

Dexpanthenol is included to engage mechanisms critical for tissue recovery. Once absorbed, it is enzymatically converted into D-pantothenic acid, which is an essential precursor for Coenzyme A (CoA). Coenzyme A is a fundamental cofactor in metabolic pathways necessary for protein and lipid synthesis. This action contributes to the activation of regenerative processes by influencing the rate of fibroblast proliferation and re-epithelialization of cellular structures.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Dolobene Gel is an external preparation strictly intended for dermal use (topical application) onto the skin surface. The use of this combination product is governed by specific instructions concerning dosage, frequency, and application conditions.

Feature Official Labeled Instruction
Route of Administration Dermal (Topical) application.
Dosing Schedule Apply a gel strand of approximately 3 cm in length per application.
Frequency Pattern Apply to the affected area 2 to 4 times daily

Labeled Procedural Instructions

The method of use requires the gel to be applied thinly and spread evenly over the treatment area. The application site must be clean and free of any other pharmaceutical or cosmetic products before the gel is applied. This method is crucial for proper topical use.

A key administration condition specifies that if a dressing or bandage is required, a brief period of time must elapse to allow the product to be largely absorbed or for the product's alcoholic components to evaporate before covering the site. The product is restricted from application onto mucous membranes, open wounds, or previously damaged skin.

Duration and Population Rules

The duration of application is dependent on the severity and overall course of the localized complaints. Use should be reviewed by a qualified specialist if symptoms show no improvement after approximately 10 days. The labeled instructions prohibit use in children under 5 years of age due to a lack of sufficient clinical experience in this younger population. Due to the potential for increased photosensitivity from an active component, patients are instructed to avoid intensive sun exposure and the use of solariums during the treatment course.

Advertisements

Recent Clinical Evidence

Dolobene (Heparin): Recent Clinical Evidence

Recent clinical research on topical formulations containing heparin and dimethyl sulfoxide (DMSO), the active components of Dolobene, has focused primarily on local inflammatory conditions and localized injuries.

Efficacy in Superficial Vein Thrombophlebitis (SVT)

Studies have investigated the use of high-dose topical heparin gel (e.g., 2400 IU/g) in the management of superficial vein thrombophlebitis (SVT). Research findings indicate that topical heparin may support symptom reduction in this condition. One study reported symptom improvement in the majority of patients, noting reductions in measures of pain, venous redness, and edema after two weeks of use.

  • Comparative Data: A literature review of multiple clinical trials found that topical heparin demonstrated greater effectiveness compared to placebo in reducing SVT symptoms. Some evidence also suggests that high-dose topical heparin may have comparable efficacy to certain low-molecular-weight heparins (LMWH) in injectable form for symptom relief in SVT.

Role of Combination Components

Clinical evaluation of the combination components suggests distinct roles for each active substance:

Component Proposed Mechanism of Action (Topical Focus)
Heparin Research explores its localized anti-inflammatory, anti-exudative (anti-swelling), and microcirculatory modulating properties, separate from its systemic anticoagulant effect.
DMSO Investigated for its ability to enhance the skin penetration of other co-administered substances, and for its own documented potential anti-inflammatory and analgesic properties.

Other Exploratory Research

Limited exploratory studies have also examined the topical application of heparin-containing gels for other localized issues, such as reducing hand-foot syndrome (HFS) symptoms associated with certain chemotherapy agents. Findings from a small-scale trial suggested a numerical difference in the reduction of erythema (redness) and swelling when topical heparin gel was used as a supportive measure.

Key Studies & References

  1. The Effect of Topical Heparin Gel on Reducing Hand–Foot Syndrome Symptoms in Cancer Patients Treated with Capecitabine
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dolobene (Heparin) (FAQ)

Q: What is the difference between Dolobene and a regular pain rub?

According to the official product information, Dolobene is classified as a combination topical anticoagulant and anti-inflammatory agent. Its distinguishing feature is its triple composition, including Heparin for anti-swelling properties, Dimethyl Sulfoxide (DMSO) which acts as a penetration enhancer, and Dexpanthenol to support tissue regeneration. This combination of three active components is what distinguishes it from many single-action topical products.


Q: How long does the effect of one application of Dolobene typically last?

Official administration instructions advise applying the gel to the affected area 2 to 4 times daily. This frequency is specified in official instructions for use.


Q: What happens if I forget to apply Dolobene at the scheduled time?

Official guidance regarding a missed application advises against applying a double amount to compensate. Instead, the guidance states the next application is the usual amount applied at the next scheduled time.


Q: Can using too much Dolobene cause problems?

Official documentation indicates that no overdose symptoms are expected if a patient accidentally uses large amounts of the topical gel. The product is applied according to the specific directions provided in the patient information leaflet.


Q: What should I look out for as a sign of a serious side effect from Dolobene?

The official safety profile describes serious adverse reactions as being rare hypersensitivity manifestations, such as systemic allergic responses. These types of reactions, while not common, are described as serious events in the safety profile.


Q: Does Dolobene help with muscle soreness after exercise?

The official regulatory indications specify that the gel is intended for the supportive treatment of swelling, bruising, and inflammation following blunt injuries to structures like muscles, tendons, and ligaments. This includes common issues such as strains and sprains.


Q: What population groups are typically excluded from using Dolobene?

Official product information prohibits use in several patient groups due to safety restrictions. These groups include those with known hypersensitivity to any component, patients with bronchial asthma, severe liver or kidney dysfunction, or circulatory instability. It is also prohibited for use during pregnancy, breastfeeding, and in children under 5 years of age.


Q: What are the different strengths or concentrations of Dolobene available?

The official product information specifies the concentration of the active ingredients in the marketed gel. This concentration is listed as Heparin sodium (50,000 I.U./100 g), Dimethyl Sulfoxide (15 g/100 g), and Dexpanthenol (2.5 g/100 g).


Q: Are there specific body parts where Dolobene should not be applied?

Yes, official procedural instructions strictly prohibit application on certain areas. The gel must not be applied to mucous membranes (such as the eyes, mouth, or nose), on open wounds, or on skin that is diseased or otherwise previously damaged.


Q: Does using Dolobene affect blood tests or international normalized ratio (INR)?

The potential for systemic exposure requires caution in patients with severe liver or kidney dysfunction, according to the official safety profile. Official documentation notes that the extent of Heparin's influence on blood clotting parameters and tests like the INR following topical use is not consistently quantified in product labels.


Q: Can I use Dolobene at the same time as taking aspirin or ibuprofen?

Regulatory documents indicate that co-administration with other medications that affect blood clotting, such as systemic anticoagulants or antiplatelet agents (like aspirin), may lead to a reinforcement effect. This may increase the potential for localized adverse outcomes like bruising or bleeding.


Q: Is there any research evidence on how well Dolobene works for sports injuries?

The product is officially indicated for the supportive treatment of inflammation, swelling, and bruising following blunt injuries to muscles, ligaments, and joints. This indication covers common sports-related issues such as strains, sprains, and specifically mentions the condition known as tennis elbow.


Q: Are there any studies comparing the effectiveness of different heparin topical formulations?

Clinical studies have included comparative data showing the efficacy of high-dose topical heparin gel versus placebo and versus injectable low-molecular-weight heparins for symptom relief in conditions like superficial vein thrombophlebitis. Some evidence also compares the efficacy of topical heparin gel against other heparinoid creams.


Q: Can I apply makeup or cosmetics over the area where I've used Dolobene?

Official administration advice specifies that the application area must be clean and free of cosmetic products before the gel is applied. If the treated area needs to be covered with a bandage or dressing, a few minutes must pass to allow the product to absorb or for its alcoholic components to evaporate before the site is covered.


Q: Is the main ingredient, Heparin, absorbed into the bloodstream from the skin?

The official safety profile includes cautionary statements regarding use in patients with severe hepatic or renal dysfunction. This implies a potential for some systemic exposure and subsequent clearance of the active ingredients and their metabolites by the body.


Q: Does Dolobene have any known interactions with herbal supplements?

Official regulatory documents explicitly state that no specific interactions between the topical gel and herbal supplements are explicitly documented in regulatory labels.


Q: Why is Dolobene sometimes recommended for treating hematomas (bruises)?

The gel is officially indicated for the supportive treatment of bruising (hematomas) following minor blunt injuries. This is supported by the combined action of its ingredients, particularly Heparin, which provides anti-exudative (anti-swelling) and anti-inflammatory properties.


Q: How does the official literature describe the general expected outcome of using Dolobene?

The product is described in official literature as having an anti-inflammatory, anticoagulant, and analgesic effect at the site of application. Its general expected outcome is to counteract swelling and provide localized supportive care.


Q: Is Dolobene known to interact with certain foods or drinks?

Official regulatory documents explicitly state that no specific interactions between the topical gel and certain foods or drinks are explicitly documented in regulatory labels.


Q: Does using Dolobene affect the skin's color or texture over time?

The official safety profile lists transient local skin reactions such as redness (erythema), itching, and burning as common side effects. However, it does not document any permanent or long-term changes to the skin's color or texture over the course of treatment.


Q: Can I use Dolobene on areas of skin that have a rash or eczema?

Application of the gel is strictly prohibited on diseased skin, which includes areas affected by conditions like a rash or eczema, or on skin that is otherwise previously damaged.


Q: Does the strength of heparin in Dolobene determine its effectiveness?

Research on topical heparin formulations suggests that higher concentrations, such as the 50,000 I.U./100g concentration in this product, may be important factors influencing localized effectiveness. The inclusion of Dimethyl Sulfoxide (DMSO) as a penetration enhancer is also cited as contributing to the delivery of the active ingredients.


Q: Can Dolobene be used for conditions like tennis elbow or golfer's elbow?

The product is officially indicated for the supportive treatment of blunt injuries to tendons and joints, and the condition commonly known as tennis elbow is specifically listed.

Advertisements

How should Dolobene (Heparin) be stored and disposed of?

The storage and disposal of Dolobene gel are governed by specific requirements to maintain product stability and ensure proper handling of pharmaceutical waste.

Official Storage Conditions

Requirement Stated Condition
Maximum Temperature Do not store above 25 C (77 F).
Container Integrity The tube must be closed carefully after each use.
Stability After Opening Usable for 12 months after the first opening, but not past the original expiration date.
Child Safety Keep out of the reach and sight of children.

Official Disposal Instructions

Do not dispose of this medicine via wastewater or ordinary household waste. To ensure proper environmental protection, users are instructed to ask a pharmacist for the correct procedure to dispose of unused or expired product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolobene (Heparin) found in:

A-Z Index: